Skip Main Navigation Links Jump to Footer
Nucleic Acids ResearchVolume 37, Issue 8, 2009, Article number e64

Rapid antibody selection by mRNA display on a microfluidic chip(Article)

  • aDepartment of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan
  • bBiomarker Research Group, Molecuence Corporation, Yokohama 227-8502, Japan

Abstract

In vitro antibody-display technologies are powerful approaches for isolating monoclonal antibodies from recombinant antibody libraries. However, these display techniques require several rounds of affinity selection which is time-consuming. Here, we combined mRNA display with a microfluidic system for in vitro selection and evolution of antibodies and achieved ultrahigh enrichment efficiency of 106-to 108-fold per round. After only one or two rounds of selection, antibodies with high affinity and specificity were obtained from naïve and randomized single-chain Fv libraries of ∼1012 molecules. Furthermore, we confirmed that not only protein-protein (antigen-antibody) interactions, but also protein-DNA and protein-drug interactions were selected with ultrahigh efficiencies. This method will facilitate high-throughput preparation of antibodies and identification of protein interactions in proteomic and therapeutic fields.

Indexed keywords

EMTREE drug terms:messenger RNAprotein MDM2protein p53
EMTREE medical terms:antibody affinityantibody isolationarticlecell selectioncontrolled studydifferential displaydrug protein bindinghigh throughput screeninghumanhuman cellin vitro studymicrofluidic analysismolecular evolutionmousenonhumanpriority journalprotein analysisprotein DNA interactionprotein protein interactionproteomicsanimalbiosynthesiscell linedirected molecular evolutionevaluationgene librarygenetic transcriptiongeneticsimmunoglobulin variable regionimmunologymethodologyprotein synthesis
MeSH:AnimalsCell LineDirected Molecular EvolutionGene LibraryHumansImmunoglobulin Variable RegionMiceMicrofluidic Analytical TechniquesProtein BiosynthesisProto-Oncogene Proteins c-mdm2RNA, MessengerTranscription, GeneticTumor Suppressor Protein p53

Chemicals and CAS Registry Numbers:

Immunoglobulin Variable Region; Proto-Oncogene Proteins c-mdm2, 6.3.2.19; RNA, Messenger; Tumor Suppressor Protein p53

Funding details

Funding numberFunding sponsorAcronymFunding opportunities
Keio UniversityKeio
05
  • 1

    Grant-in-Aid for Scientific Research; Special Coordination Fund grant from the MEXT of Japan; the Industrial Technology Research Grant Program in ‘05 from the NEDO of Japan. Funding for open access charge: Keio University.

  • ISSN: 03051048
  • CODEN: NARHA
  • Source Type: Journal
  • Original language: English
  • DOI: 10.1093/nar/gkp184
  • PubMed ID: 19336414
  • Document Type: Article

  Yanagawa, H.; Department of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Japan;
© Copyright 2009 Elsevier B.V., All rights reserved.

Cited by 24 documents

Kennedy, P.J. , Oliveira, C. , Granja, P.L.
Monoclonal antibodies: technologies for early discovery and engineering
(2018) Critical Reviews in Biotechnology
Nakayama, M. , Komiya, S. , Fujiwara, K.
In vitro selection of bispecific diabody fragments using covalent bicistronic DNA display
(2016) Biochemical and Biophysical Research Communications
Nagumo, Y. , Fujiwara, K. , Horisawa, K.
PURE mRNA display for in vitro selection of single-chain antibodies
(2016) Journal of Biochemistry
View details of all 24 citations